American Family Children's Hospital
SHARE TEXT

UW Health ACO Governance

ACO Name and Location

 

UW Health ACO

University Crossing Building

749 University Row, Suite 251

Madison, WI 53705

 

ACO Primary Contact

 

Jonathan Jaffery, MD

President and CEO, UW Health ACO

Email:  uwhealthaco@uwhealth.org

Phone:  (608) 821-4998

 

Organizational Information

 

ACO participants:

ACO participants in joint ventures between ACO professionals and hospitals:

 

No participants are involved in a joint venture between ACO professionals and hospitals.

 

ACO governing body:

  • Robert Golden, MD. Voting Member and Chair. Dean, University of Wisconsin School of Medicine and Public Health.
  • Alan Kaplan, MD. Voting Member. CEO, UW Health.
  • Jonathan Jaffery, MD. Voting Member. President and Chief Executive Officer, UW Health ACO; Chief Population Health Officer, UW Health.
  • Ken Mount. Voting Member. CFO, University of Wisconsin School of Medicine and Public Health.
  • Pete Newcomer, MD. Voting Member. Chief Medical Officer, UW Health.
  • Ron Sliwinski. Voting Member. President, UW Hospitals and Chief of Clinical Operations, UW Health.
  • David Kindig, MD. Voting Member. Medicare Beneficiary.
  • Sarah Davis. Voting Member. Consumer Advocate.

Key ACO clinical and administrative leadership:

  • ACO Executive: Jonathan Jaffery, MD
  • Medical Director: Jeff Huebner, MD
  • Compliance Official: Steve Means

Associated committees and committee leadership:

  • UW Health ACO Finance Committee: Robert Flannery, Chair
  • UW Health ACO Administration and Operations Team: Jonathan Jaffery, MD, Co-Chair; Stephanie Berkson, Co-Chair
  • Patient Safety and Quality Committee: Katharyn May, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals

Shared Savings and Losses

 

Amount of Shared Savings/Losses

  • Agreement Period beginning 2013, Performance Year 2013: $0
  • Agreement Period beginning 2013, Performance Year 2014: $0
  • Agreement Period beginning 2013, Performance Year 2015: $0

Payment Rule Waivers

 

No, our ACO does not utilize the SNF 3-Day Rule Waiver.

 

Shared Savings Distribution 

 

Shared Savings are reinvested back into care coordination activities. Any remaining funds are distributed back to the participant organizations.

 

Quality Performance Results

 

 

Measure number

Measure Name

2015 reporting period

ACO

performance rate

Mean performance rate

(SSP ACOs)

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

85.97

80.61

ACO-2

CAHPS: How Well Your Doctors Communicate

91.80

92.65

ACO-3

CAHPS: Patients' Rating of Doctor

91.63

91.94

ACO-4

CAHPS: Access to Specialists

82.88

83.61

ACO-5

CAHPS: Health Promotion and Education

58.29

59.06

ACO-6

CAHPS: Shared Decision Making

74.76

75.17

ACO-7

CAHPS: Health Status/Functional Status

73.81

72.30

ACO-34

CAHPS: Stewardship of Patient Resources*

22.76

26.87

ACO-8

Risk Standardized, All Condition Readmissions^

14.35

14.86

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) Readmission*^

18.03

18.07

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes*^

43.38

54.60

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure*^

66.21

76.96

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions*^

55.10

62.92

ACO-9

ASC Admissions: COPD or Asthma in Older Adults^

0.60

1.11

ACO-10

ASC Admission: Heart Failure^

0.84

1.04

ACO-11

Percent of PCPs who Qualified for EHR Incentive Payment

100.00%

76.22%

ACO-39

Documentation of Current Medications in the Medical Record*

94.63%

84.07%

ACO-13

Falls: Screening for Fall Risk

73.83%

56.46%

ACO-14

Influenza Immunization

90.36%

62.03%

ACO-15

Pneumococcal Vaccination

94.38%

63.73%

ACO-16

Adult Weight Screening and Follow-up

62.20%

71.15%

ACO-17

Tobacco Use Assessment and Cessation Intervention

98.01%

90.16%

ACO-18

Depression Screening

52.10%

45.25%

ACO-19

Colorectal Cancer Screening

81.91%

60.06%

ACO-20

Mammography Screening

82.27%

65.67%

ACO-21

Proportion of Adults who had blood pressure screened in past 2 years

70.03%

70.04%

ACO-40

Depression Remission at Twelve Months*

N/A

N/A

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control^

7.01%

20.38%

ACO-41

Diabetes: Eye Exam*

64.58%

41.05%

ACO-28

Hypertension: Controlling High Blood Pressure

79.72%

69.62%

ACO-30

Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic

93.73%

83.82%

ACO-31

Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

93.10%

87.22%

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

88.42%

77.73%

CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.

*= Measure required beginning Reporting Year 2015.

N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A

^=These measures are reverse-scored. Lower scores for these measure indicate better performance.

 

More information on how to interpret scores on the above quality performance measures

 

UW Health ACO Compliance Reporting

 

Please submit concerns to:

 

Steve Means, Compliance Officer, UW Health ACO, Inc.

7974 UW Health Court

Middleton, WI 53562

ACOCompliance@uwhealth.org

 

Anonymous UW Health ACO Reporting Hotline (8am–5pm Central, Monday-Friday)

  • (608) 821-4130 (local)
  • (888) 225-8282 (toll free)